FDA Inspection
Murty Pharmaceuticals, IncMurty Pharmaceuticals, Inc – FDA Inspection, Mar 28, 2025
Record Details
This FDA Inspection record concerns Murty Pharmaceuticals, Inc, with an inspection on March 28, 2025, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · 2b083c05-1eac-4b54-8466-47d2b64e2225
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1265169
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.182Specific information required in individual logs
- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Murty Pharmaceuticals, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2019 | Not classified | Cincinnati District Office | |
| January 14, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 15, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 22, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 14, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Murty Pharmaceuticals, Inc
- FDA Inspection 1087619 - 2019-04-17
- FDA Inspection 1077569 - 2019-01-14
- FDA Inspection 858433 - 2013-11-15
- FDA Inspection 732158 - 2011-06-22
- FDA Inspection 680956 - 2010-09-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.